1Li EC, Davis LE. Zoledronic acid: a new parenteral bisphosphonate[J]. Clin Ther, 2003, 25 (11): 2669-2708.
2Penning - van Beest FJ, Erkens JA, Olson M, et al. Loss of treatment benefit due to low compliance with bisphosphonate therapy [J]. Osteoporos Int, 2008, 19 (4) : 511 -517.
3Cramer JA, Gold DT, Silverman SL, et al. A systematic review of persistence and compliance with bisphosphonates for osteoporosis [J]. Osteoporos Int, 2007, 18 (8):1023-1031.
4Black DM, Delmas PD, Eastell R, et al. Once - yearly zoledronic acid for treatment of postmenopausal osteoporosis [ J ]. N Engl J Med, 2007, 356 (18): 1809-1822.
5Lyles KW, Col6n - Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture[J]. N Engl J Med, 2007, 357 (18) : 1799 -1809.
6Lewiecki EM. Intravenous zoledronic acid tbr the treatment of osteoporosis[J]. Curr Osteoporos Rep, 2008, 6 (1): 17 -23.
7Reid IR, Miller P, Lyles K, et al. A single infusion of zoledronic acid improves remission rates in Paget's disease : a randomized controlled comparison with risedronate [J]. N Engl J Med, 2005, 353 (9) : 898 - 908.
5Reid IR,Brown JP,Burckhardt P,et al.Intravenous zoledronic acid in postmenopausal women with low bone mineral density[J].N Engl J Med,200,346(9):653-661.
6Lyles KW,Colón-Emeric CS,Magaziner JS,et al.Zoledronic acid and clinical fractures and mortality after hip fracture[J].Engl J Med,2007,357:1799-1809.
7Louis-Georges Ste-Marie,Louis-Georges Ste-Marie,Andree Boucher,Ages Rakel.Role of zoledronic acid in the prevention and treatment of osteoporosis[J]. Clinical Interventions in Aging . 2011 (default)
8Robert Coleman,Roger Burkinshaw,Matthew Winter,Helen Neville-Webbe,Jim Lester,Emma Woodward,Janet Brown.Zoledronic acid[J]. Expert Opinion on Drug Safety . 2011 (1)
9I. R. Reid,G. D. Gamble,P. Mesenbrink,P. Lakatos,D. M. Black.Characterization of and Risk Factors for the Acute-Phase Response after Zoledronic Acid[J]. The Journal of Clinical Endocrinology & Metabolism . 2010 (9)
10E. Michael Lewiecki.Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect[J]. Core Evidence . 2009 (default)
